Publication | Closed Access

Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial

Family MedicineType 1Diabetes ManagementInsulin ManagementDiabetesGynecologyGestational DiabetesMaternal HealthPregnant WomenDiabetes MellitusInsulin DeliveryInsulin DetemirMedicine